Treatment Information

Back

Mesothelioma treatment details. Chemotherapy.

The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States.

Survival: monthsCountry:United States
Toxiciy Grade:4City/State/Province:Houston, Texas
Treatments:ChemotherapyHospital:The University of Texas M.D. Anderson Cancer Center
Drugs:Journal:Link
Date:Aug 2000

Description:

Patients: This Phase II study involved 24 patients with malignant pleural mesothelioma

Treatment: The treatment consisted of the administration of the drug Doxil.

Toxicity: Toxicities included cardiac, mild elevations of alkaline phosphatase, nausea, and hematological. One patient had a grade 4 neutropenia.

Results: No objective responses were observed and the overall median survival was 37 weeks (8.5 months).

Support: The study was supported in part by Sequus Pharmaceuticals, Inc. Sequus manufactures Doxil.

Correspondence: Dong M. Shin, MD




Back